ATE267397T1 - Reagenz zum nachweis und weiterverfolgen von virusinfektionen - Google Patents

Reagenz zum nachweis und weiterverfolgen von virusinfektionen

Info

Publication number
ATE267397T1
ATE267397T1 AT98935098T AT98935098T ATE267397T1 AT E267397 T1 ATE267397 T1 AT E267397T1 AT 98935098 T AT98935098 T AT 98935098T AT 98935098 T AT98935098 T AT 98935098T AT E267397 T1 ATE267397 T1 AT E267397T1
Authority
AT
Austria
Prior art keywords
aminoacids
reagent
infection
detecting
fragment
Prior art date
Application number
AT98935098T
Other languages
English (en)
Inventor
Bunel Denis Tranchand
Masse Helene Gras
Claude Auriault
Andre Tartar
Eric Diesis
Brigitte Bourez
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE267397T1 publication Critical patent/ATE267397T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/05—Epstein-Barr virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98935098T 1997-07-04 1998-07-03 Reagenz zum nachweis und weiterverfolgen von virusinfektionen ATE267397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708537A FR2765688B1 (fr) 1997-07-04 1997-07-04 Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
PCT/FR1998/001432 WO1999001767A1 (fr) 1997-07-04 1998-07-03 Reactif de detection et suivi des infections virales

Publications (1)

Publication Number Publication Date
ATE267397T1 true ATE267397T1 (de) 2004-06-15

Family

ID=9508900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98935098T ATE267397T1 (de) 1997-07-04 1998-07-03 Reagenz zum nachweis und weiterverfolgen von virusinfektionen

Country Status (9)

Country Link
US (1) US6818219B1 (de)
EP (1) EP0993616B1 (de)
JP (1) JP2001517247A (de)
AT (1) ATE267397T1 (de)
AU (1) AU746231B2 (de)
CA (1) CA2295962A1 (de)
DE (1) DE69824001T2 (de)
FR (1) FR2765688B1 (de)
WO (1) WO1999001767A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090036653A1 (en) * 2006-04-13 2009-02-05 Peptimmune, Inc. Methods for the directed expansion of epitopes for use as antibody ligands
US8378072B2 (en) * 2006-04-13 2013-02-19 Declion Pharmaceuticals, Inc. Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
US20100298547A1 (en) * 2007-05-07 2010-11-25 Dustan Bonnin Methods for the directed expansion of epitopes for use as antibody ligands
WO2009051797A1 (en) * 2007-10-16 2009-04-23 Peptimmune, Inc. Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes
AU2009236583B2 (en) * 2008-04-17 2015-07-16 Declion Holdings Llc Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
DE102013001699A1 (de) * 2013-02-01 2014-08-07 Euroimmun Medizinische Labordiagnostika Ag Verfahren und Vorrichtung zur Diagnose eines Nasopharynx-Karzinoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット
KR100257941B1 (ko) * 1992-03-06 2000-06-01 휴버스윗 에이치. 밴 면역학적으로 중요한 에피토프에 상응하는 펩티드의 측정 방법 및 면역학적으로 중요한 에피토프에 상응하는 항체 또는 비오티닐화된 펩티드의 측정 방법에 상기 펩티드를 사용하는 방법, 상기 펩티드의 제조 방법 및 상기 펩티드를 함유하는 조성물
ATE380243T1 (de) * 1992-03-13 2007-12-15 Biomerieux Bv Epstein-barr-virus verwandte peptide und nukleinsäuresegmente
EP0649904B1 (de) * 1993-09-14 2003-01-22 bioMérieux BV Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
FR2721618B1 (fr) * 1994-06-28 1996-09-13 Centre Nat Rech Scient Fragments d'acide nucléique et fragments peptidiques correspondants issus du génome du virus de l'arthrite et de l'encéphalite caprine (VAEC) et leurs applications.
US6506553B1 (en) * 1995-03-30 2003-01-14 Ortho Diagnostics Systems, Inc. Method for diagnosis of Epstein-Barr virus associated disease
DE19526384C2 (de) * 1995-07-19 1997-07-10 Biotest Ag Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, sowie diese enthaltende Testkits zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern

Also Published As

Publication number Publication date
JP2001517247A (ja) 2001-10-02
AU746231B2 (en) 2002-04-18
AU8446598A (en) 1999-01-25
DE69824001T2 (de) 2006-02-09
EP0993616A1 (de) 2000-04-19
WO1999001767A1 (fr) 1999-01-14
FR2765688B1 (fr) 1999-09-10
CA2295962A1 (fr) 1999-01-14
DE69824001D1 (de) 2004-06-24
FR2765688A1 (fr) 1999-01-08
US6818219B1 (en) 2004-11-16
EP0993616B1 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
DE60333963D1 (de) Zytokin Ligand zur Behandlung von Asthma und Atemwegsüberreaktivität
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
DE59109271D1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DE122005000039I1 (de) DNS-Fragmente des GAG-Gens von LAV
DE69838143D1 (de) Antimikrobielle peptide
BR0010720A (pt) Peptìdeos de neisseria antigênicos
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE495247T1 (de) Chromoprotein und fluoroproteine
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
DE69824001D1 (de) Reagenz zum nachweis und weiterverfolgen von virusinfektionen
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE408685T1 (de) Antimikrobielle peptide, abstammend von ubiquicidin
ATE477272T1 (de) Verwendung von stefin a als gerüstprotein
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
ATE431414T1 (de) Transportpeptide abgeleitet von erns protein
DE69128039D1 (de) Allergene aus roggenspreupollen
SE9901601D0 (sv) Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
ATE214941T1 (de) Verwendung von interferon alpha 5 in der behandlung viraler hepatopathien
DE69017352D1 (de) An HIV relatierte Peptide.
DE60120357D1 (de) Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff
CA2262500A1 (en) Measles virus mutant antigen and gene coding for the same
GB2441941A (en) An isolated recombinant vaccinia virus complement control protein (HRVCP) polypeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties